Roberta Elisa Rossi

Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens.

V. Torri, I. Floriani, N. Colombo, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.